[RE]MEDs
[RE]MEDs is an AI-powered pharmaceutical research company focused on repurposing and repositioning existing drugs for autoimmune disorders. Leveraging billions of electronic medical records and health datasets, their technology analyzes thousands of drugs in-silico to identify new cures for diseases with significant unmet medical needs. Their research spans various autoimmune conditions, aiming to uncover the effects of commonly used drugs on these diseases. The company's business model includes proprietary and collaborative research with industry, NGOs, and academia.
[RE]MEDs
[RE]MEDs is an AI-powered pharmaceutical research company focused on repurposing and repositioning existing drugs for autoimmune disorders. Leveraging billions of electronic medical records and health datasets, their technology analyzes thousands of drugs in-silico to identify new cures for diseases with significant unmet medical needs. Their research spans various autoimmune conditions, aiming to uncover the effects of commonly used drugs on these diseases. The company's business model includes proprietary and collaborative research with industry, NGOs, and academia.